Compositions, devices and methods for factor VII therapy

Described herein are RPE cells engineered to secrete a FVII protein, as well as compositions, pharmaceutical preparations, and implantable devices comprising the engineered RPE cells, and methods of making and using the same for treating a patient with hemophilia or FVII deficiency.

Saved in:
Bibliographic Details
Main Authors JOHNSTON, Erika Ellen, OBERLI, Matthia Alexander, WOTTON, Paul Kevin, YIN, Zoe, HEIDEBRECHT, Richard, VEISEH, Omid, SEWELL, Jared A, CARMONA, Guilaume, GONZALES, Francisco Caballero, BEAUREGARD, Michael, O'CONNER, Owen, MILLER, Robert James, PERITT, David, SMITH, Devyn McKinley, BARNEY, Lauren Emily
Format Patent
LanguageEnglish
Published 16.09.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Described herein are RPE cells engineered to secrete a FVII protein, as well as compositions, pharmaceutical preparations, and implantable devices comprising the engineered RPE cells, and methods of making and using the same for treating a patient with hemophilia or FVII deficiency.
Bibliography:Application Number: AU20200248101